Infectotrimet 100 Saft

Trimethoprim, the active ingredient in Infectotrimet 100 Saft, is an antibacterial drug presented as an oral solution for oral administration. It inhibits bacterial folic‑acid synthesis and is indicated for the treatment of uncomplicated urinary tract infections in both adult and pediatric patients when prescribed by a qualified health professional.

GNH USA supplies Infectotrimet 100 Saft as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for export to EU and other markets.

Trimethoprim is an antibacterial agent used primarily in the urinary tract infection pathway. - Uncomplicated urinary tract infection: eradicates susceptible bacteria, relieving symptoms and preventing progression. - Acute pyelonephritis: contributes to bacterial clearance in kidney infection when combined with appropriate therapy. - Recurrent urinary tract infection prophylaxis: reduces incidence of repeat infections during preventive treatment. - Travelers' diarrhea (susceptible strains): helps clear infection caused by enteric bacteria.

Trimethoprim may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Nausea: mild stomach upset or queasiness. - Vomiting: occasional expulsion of stomach contents. - Diarrhea: loose stools, often transient. - Skin rash: mild erythematous eruption. - Elevated serum creatinine: reversible increase in kidney function markers. - Headache: mild to moderate head discomfort.

Serious or Rare Side Effects: - Severe allergic reaction: anaphylaxis with airway compromise. - Blood dyscrasias: agranulocytosis, aplastic anemia, or leukopenia. - Hepatotoxicity: marked elevation of liver enzymes. - Stevens‑Johnson syndrome: severe mucocutaneous blistering. - Renal toxicity: acute interstitial nephritis. - Hemolytic anemia in G6PD deficiency: rapid destruction of red blood cells.

When prescribing trimethoprim, clinicians should consider several precautionary measures to ensure safe use. - Renal function: adjust use in patients with impaired kidney function. - Hepatic impairment: monitor liver enzymes in patients with liver disease. - Drug hypersensitivity: avoid in individuals with known allergy to trimethoprim or sulfonamides. - Pregnancy: assess risk‑benefit as safety data are limited. - Concomitant folate antagonists: avoid simultaneous use with methotrexate or pyrimethamine. - Store at ambient temperature: keep below 25 °C, in original container, protect from moisture and light.

Trimethoprim can interact with several medicines, altering efficacy or increasing toxicity.

Major Interactions (Avoid): - Warfarin: increased anticoagulant effect, risk of bleeding. - Methotrexate: additive folate antagonism, heightened toxicity. - Phenytoin: reduced plasma levels, decreased seizure control.

Moderate Interactions (Monitor Closely): - Digoxin: elevated serum concentrations, monitor cardiac status. - Oral contraceptives: decreased effectiveness, advise backup contraception. - Rifampin: induces metabolism, may lower trimethoprim levels. - NSAIDs: potential for renal impairment, monitor kidney function.